Track the 파멥신 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 파멥신 has logged 63 public disclosures. The latest transaction was reported on 27 September 2024 (Sale). Among the most active insiders: 김재현. Every trade is accessible without an account.
63
Insider Decl.
n/a
Thresholds
n/a
24 ops.
Buy Volume
n/a
5 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
파멥신 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative treatments for various diseases.